SkinCeuticals, globally recognised as the #1 Medical Aesthetic Skincare Brand Worldwide, has officially announced its expansion into the New Zealand market, launching nationwide on 17th September 2026. The highly anticipated launch introduces the brand’s clinical-grade formulations to Kiwi consumers and health care professionals, bringing decades of peer-reviewed antioxidant science and innovation to local clinics and at-home skincare routines.
Founded in 1997 by visionary dermatologist, chemist, and research scientist Dr. Sheldon Pinnell, SkinCeuticals was born from academic science and a mission to improve skin health. The brand’s foundation rests upon the renowned Duke Antioxidant patent, a groundbreaking formulation standard established by Dr. Pinnell that dictated the precise parameters, including the exact concentration and pH levels, required for the effective delivery of topical vitamin C to the skin. Today, validated by extensive physician testing, the brand operates on a triple-pillar philosophy born from that exact scientific rigor: Prevent, Correct, and Protect.
“Bringing SkinCeuticals to New Zealand marks an exciting milestone for us. We’ve seen incredible demand from local dermatologists and skin specialists who want our formulations in their practices,” explains Dr. Tania Romano, SkinCeuticals, Head of Medical & Education. “We know New Zealanders are deeply invested in skin health, and we look forward to delivering the world’s #1 medical aesthetic skincare brand and its clinically proven formulations to local clinics and customers alike.”
At the center of the New Zealand launch is SkinCeuticals’ globally celebrated hero product, C E Ferulic. Formulated with a blend of 15% pure vitamin C (L-ascorbic acid), 1% vitamin E (alpha tocopherol), and 0.5% ferulic acid, this high-potency daytime antioxidant serum delivers advanced environmental defense against atmospheric aging caused by UVA/UVB radiation, ozone pollution, and free radicals.
Beyond neutralising environmental stressors, C E Ferulic is proven to visibly reduce 10 years of aging signs. Once absorbed into the skin, the potent formula remains effective for a minimum of 72 hours, delivering sustained protection alongside rigorous clinical data that demonstrates:
- A 36% reduction in the appearance of fine lines and wrinkles*
- A 41% reduction in skin discoloration*
- Visible improvements in overall skin firmness and radiance*
*Cosmeto-clinical study, 52 subjects, after 20 weeks of use.
Trusted and recommended by more than 10,000 clinics worldwide, SkinCeuticals champions a progressive Integrated Skincare strategy. By bridging the gap between professional aesthetic procedures and daily at-home regimens, the brand provides solutions designed to complement, protect, and amplify in-clinic treatment outcomes. Highlighting its role as an essential partner in comprehensive patient care, C E Ferulic has been physician-tested for use post-laser treatments to help reduce downtime. With its New Zealand arrival, SkinCeuticals aims to redefine the local standard of patient care, equipping health care professionals with the highest quality formulations backed by uncompromised clinical proof.
SkinCeuticals products will be made available through partner cosmetic clinics and dermatologists nationwide. For more information on SkinCeuticals and the science behind the brand, visit www.skinceuticals.com.au.
